drugset / Trial / NCT01353976

Safety and Efficacy of Econazole Nitrate Foam 1% in Subjects With Tinea Pedis

NCT01353976 ↗

Phase 3 Completed 264 enrolled AmDerma AmDerma Pharmaceuticals, LLC · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a study of the safety and efficacy of topical Econazole Nitrate Foam 1% and the foam vehicle in subjects with interdigital tinea pedis (athlete's foot between the toes). This is a 6 week study which has a 4 week treatment period and a 2 week follow-up evaluation.

Timeline

Start
2011-05
Primary completion
2012-04
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Econazole Nitrate Unknown 1 % Topical

Indications